Dabigatran acyl-β-D-glucuronide-d3 (TFA)

• UNSPSC Description:

  Dabigatran acyl-β-D-glucuronide-d3 (TFA) is the deuterium labeled Dabigatran Acyl-β-D-Glucuronide trifluoroacetate[1].

• Target Antigen:

  Isotope-Labeled Compounds

• Type:

  Isotope-Labeled Compounds

• Related Pathways:

  Others

• Field of Research:

  Others

• Solubility:

  10 mM in DMSO

• Smiles:

  OC([C@H]([C@H]([C@@H]([C@H]1O)O)O)O[C@H]1OC(CCN(C2=CC=CC=N2)C(C3=CC=C(C(N=C4CNC5=CC=C(C=C5)C(N)=N)=C3)N4C([2H])([2H])[2H])=O)=O)=O.CC(C(F)(F)F)=O

• Molecular Weight:

  762.70

• References & Citations:

  [1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported